New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group

Ghislaine L. Traber; Maria Della Volpe-Waizel; Peter Maloca; Ursula Schmidt-Erfurth; Gary Rubin; Botond Roska; M. Francesca Cordeiro; Tilman Otto; Richard Weleber; Luis Andres Lesmes; Angelo Arleo; Hendrik P.N. Scholl

doi:10.1159/000504892

New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group

Ghislaine L. Traber, Maria Della Volpe-Waizel, Peter Maloca, Ursula Schmidt-Erfurth, Gary Rubin, Botond Roska, M. Francesca Cordeiro, Tilman Otto, Richard Weleber, Luis Andres Lesmes, Angelo Arleo, Hendrik P.N. Scholl

Ophthalmology

Research output: Contribution to journal › Review article

1 Scopus citations

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard to both pathophysiological insight and treatment. In this context, discussing possible outcome measures in glaucoma trials is of utmost importance and clinical relevance. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on "New Technologies for Outcome Measures in Retina and Glaucoma," addressing both functional and structural outcomes, as well as translational hot topics in glaucoma and retina research. In conjunction with the published literature, this review summarizes the meeting focusing on glaucoma.

Original language	English (US)
Pages (from-to)	88-96
Number of pages	9
Journal	Ophthalmic Research
Volume	63
Issue number	2
DOIs	https://doi.org/10.1159/000504892
State	Published - Mar 1 2020

Keywords

Glaucoma
Neurodegeneration
Outcome measure
Retinal ganglion cell
Structure-function correlation

ASJC Scopus subject areas

Ophthalmology
Sensory Systems
Cellular and Molecular Neuroscience

Access to Document

10.1159/000504892

Fingerprint Dive into the research topics of 'New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group'. Together they form a unique fingerprint.

Cite this

Traber, G. L., Della Volpe-Waizel, M., Maloca, P., Schmidt-Erfurth, U., Rubin, G., Roska, B., Cordeiro, M. F., Otto, T., Weleber, R., Lesmes, L. A., Arleo, A., & Scholl, H. P. N. (2020). New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group. Ophthalmic Research, 63(2), 88-96. https://doi.org/10.1159/000504892

New Technologies for Outcome Measures in Glaucoma : Review by the European Vision Institute Special Interest Focus Group. / Traber, Ghislaine L.; Della Volpe-Waizel, Maria; Maloca, Peter; Schmidt-Erfurth, Ursula; Rubin, Gary; Roska, Botond; Cordeiro, M. Francesca; Otto, Tilman; Weleber, Richard; Lesmes, Luis Andres; Arleo, Angelo; Scholl, Hendrik P.N.

In: Ophthalmic Research, Vol. 63, No. 2, 01.03.2020, p. 88-96.

Research output: Contribution to journal › Review article

Traber, Ghislaine L. ; Della Volpe-Waizel, Maria ; Maloca, Peter ; Schmidt-Erfurth, Ursula ; Rubin, Gary ; Roska, Botond ; Cordeiro, M. Francesca ; Otto, Tilman ; Weleber, Richard ; Lesmes, Luis Andres ; Arleo, Angelo ; Scholl, Hendrik P.N. / New Technologies for Outcome Measures in Glaucoma : Review by the European Vision Institute Special Interest Focus Group. In: Ophthalmic Research. 2020 ; Vol. 63, No. 2. pp. 88-96.

@article{d9efce5115b44cad910aacbfe7a8a30c,

title = "New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group",

abstract = "Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard to both pathophysiological insight and treatment. In this context, discussing possible outcome measures in glaucoma trials is of utmost importance and clinical relevance. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on {"}New Technologies for Outcome Measures in Retina and Glaucoma,{"} addressing both functional and structural outcomes, as well as translational hot topics in glaucoma and retina research. In conjunction with the published literature, this review summarizes the meeting focusing on glaucoma.",

keywords = "Glaucoma, Neurodegeneration, Outcome measure, Retinal ganglion cell, Structure-function correlation",

author = "Traber, {Ghislaine L.} and {Della Volpe-Waizel}, Maria and Peter Maloca and Ursula Schmidt-Erfurth and Gary Rubin and Botond Roska and Cordeiro, {M. Francesca} and Tilman Otto and Richard Weleber and Lesmes, {Luis Andres} and Angelo Arleo and Scholl, {Hendrik P.N.}",

year = "2020",

month = mar,

day = "1",

doi = "10.1159/000504892",

language = "English (US)",

volume = "63",

pages = "88--96",

journal = "Ophthalmic Research",

issn = "0030-3747",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - New Technologies for Outcome Measures in Glaucoma

T2 - Review by the European Vision Institute Special Interest Focus Group

AU - Traber, Ghislaine L.

AU - Della Volpe-Waizel, Maria

AU - Maloca, Peter

AU - Schmidt-Erfurth, Ursula

AU - Rubin, Gary

AU - Roska, Botond

AU - Cordeiro, M. Francesca

AU - Otto, Tilman

AU - Weleber, Richard

AU - Lesmes, Luis Andres

AU - Arleo, Angelo

AU - Scholl, Hendrik P.N.

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard to both pathophysiological insight and treatment. In this context, discussing possible outcome measures in glaucoma trials is of utmost importance and clinical relevance. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on "New Technologies for Outcome Measures in Retina and Glaucoma," addressing both functional and structural outcomes, as well as translational hot topics in glaucoma and retina research. In conjunction with the published literature, this review summarizes the meeting focusing on glaucoma.

AB - Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard to both pathophysiological insight and treatment. In this context, discussing possible outcome measures in glaucoma trials is of utmost importance and clinical relevance. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on "New Technologies for Outcome Measures in Retina and Glaucoma," addressing both functional and structural outcomes, as well as translational hot topics in glaucoma and retina research. In conjunction with the published literature, this review summarizes the meeting focusing on glaucoma.

KW - Glaucoma

KW - Neurodegeneration

KW - Outcome measure

KW - Retinal ganglion cell

KW - Structure-function correlation

UR - http://www.scopus.com/inward/record.url?scp=85078247838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078247838&partnerID=8YFLogxK

U2 - 10.1159/000504892

DO - 10.1159/000504892

M3 - Review article

C2 - 31935739

AN - SCOPUS:85078247838

VL - 63

SP - 88

EP - 96

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

IS - 2

ER -